Two trials assessed vascular endothelial growth factor (VEGF) with one reporting an increase in an ischaemic CAD group (Adams et al. 2004) and the other trial reported no change either in HFrEF or healthy groups (Van Craenenbroeck et al. 2010a). This evidence concerns the gene VEGFA and coronary artery disorder.